Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca starts late-stage study of key new cancer drug
AstraZeneca starts late-stage study of key new cancer drug
AstraZeneca starts late-stage study of key new cancer drug
Submitted by
admin
on May 8, 2014 - 10:54am
Source:
Yahoo/Reuters
News Tags:
AstraZeneca
anti-PD-L1
MEDI4736
non-small cell lung cancer
Headline:
AstraZeneca starts late-stage study of key new cancer drug
Do Not Allow Advertisers to Use My Personal information
